Workshop 6 - CAR-T Racing: Amateurs & Rookies Looking to Contribute
Saturday, September 14, 2019 03:45 PM - 05:15 PM
Plenary Hall
This session will include 3 speakers who each provide unique experiences bringing CAR T cells to patients at their institution. The session will include examples of programs that have cellular therapy experience but only utilize CAR T from other experienced centers, large programs that support many CAR T programs, as well as a program that has developed their own CAR T program from scratch. Each speaker will cover various aspects of implementing the CAR T cells, including chain of custody, labeling, and product receipt and storage.
Chair:
Patrick Hanley, PhD Children’s National Health System, USA
Speakers:
Trial and Tribulations: Lessons Learned when preparing for an Industry-Sponsored Clinical Study
Lizette Caballero, BS, MT(ASCP), UCSF Blood and Marrow Transplant Lab, USA
Learning objectives:
• Discuss the challenges of addressing discrepancies between sponsor’s procedure and in-house procedure, existing labelling system with sponsor’s requirements.
• Describe best approaches to standardization of testing and SOPs between the different industry-sponsored clinical studies.
• Share strategies use for staff training.
DIY – CAR T cells: Flipping Your Cell Therapy Lab
Paul Eldridge, PhD, UNC Lineberger Comprehensive Cancer Center, USA
Learning objectives:
• Provide overview of critical components for on-site CAR T cell manufacturing.
• Review of example process/product development timeline.
• Discussion of academic/corporate partnership models.
Drive the change: Bringing CAR-T therapies to your institution
Hema Dave, Md, MPH, Children’s National Medical Center, USA
Learning objectives:
• Provide an overview of commercially approved CAR therapies for leukemia and lymphoma
• To understand the building blocks to implement CART therapies
• Rolling out the CART program with available resources